Michael Myers

Dr. Myers is a pharmaceutical executive with over 30 years of experience in drug delivery and specialty pharmaceuticals. From 2003 to 2015, he served as CEO of Innocoll, Inc., which developed two locally applied pharmaceutical formulations based on collagen sponge through Phase 3 clinical trials for prevention of surgical site infection and treatment of acute, postoperative pain. Under his leadership, Innocoll went public in 2014. Prior to his time at Innocoll, Dr. Myers was president of the drug delivery division of West Pharmaceutical Services, president of pharmaceutical operations for Fuisz Technologies (Biovail), and held executive positions in Flamel Technologies and Elan Corporation. Dr. Myers earned his Ph.D. in Chemistry from the University College Cork. Dr. Myers also serves on the Board of Directors of Wellesley Pharmaceuticals and Venkor Pharmaceuticals.